200 related articles for article (PubMed ID: 15191668)
21. Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan.
Hildesheim A; Chen CJ; Caporaso NE; Cheng YJ; Hoover RN; Hsu MM; Levine PH; Chen IH; Chen JY; Yang CS
Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):607-10. PubMed ID: 8547826
[TBL] [Abstract][Full Text] [Related]
22. Concurrent expression of aryl hydrocarbon receptor and CYP1A1 but not CYP1A1 MspI polymorphism is correlated with gastric cancers raised in Dalian, China.
Ma JX; Zhang KL; Liu X; Ma YL; Pei LN; Zhu YF; Zhou L; Chen XY; Kong QY; Li H; Liu J
Cancer Lett; 2006 Aug; 240(2):253-60. PubMed ID: 16337337
[TBL] [Abstract][Full Text] [Related]
23. Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta.
Hakkola J; Pasanen M; Hukkanen J; Pelkonen O; Mäenpää J; Edwards RJ; Boobis AR; Raunio H
Biochem Pharmacol; 1996 Feb; 51(4):403-11. PubMed ID: 8619884
[TBL] [Abstract][Full Text] [Related]
24. Characterization of cytochrome P450 expression in human oesophageal mucosa.
Lechevrel M; Casson AG; Wolf CR; Hardie LJ; Flinterman MB; Montesano R; Wild CP
Carcinogenesis; 1999 Feb; 20(2):243-8. PubMed ID: 10069460
[TBL] [Abstract][Full Text] [Related]
25. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues.
Macé K; Bowman ED; Vautravers P; Shields PG; Harris CC; Pfeifer AM
Eur J Cancer; 1998 May; 34(6):914-20. PubMed ID: 9797707
[TBL] [Abstract][Full Text] [Related]
26. Expression of cytochrome P450 genes encoding enzymes active in the metabolism of tamoxifen in human uterine endometrium.
Hukkanen J; Mäntylä M; Kangas L; Wirta P; Hakkola J; Paakki P; Evisalmi S; Pelkonen O; Raunio H
Pharmacol Toxicol; 1998 Feb; 82(2):93-7. PubMed ID: 9498238
[TBL] [Abstract][Full Text] [Related]
27. [Expression of human cytochrome P450 2E1 gene in embryonic nasopharynx, nasopharyngeal cancer cell lines and tissue].
He ZM; Wang SL; Yuan JH; Chen ZC
Ai Zheng; 2002 Jun; 21(6):597-600. PubMed ID: 12452057
[TBL] [Abstract][Full Text] [Related]
28. Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma.
Tiwawech D; Srivatanakul P; Karalak A; Ishida T
Cancer Lett; 2006 Sep; 241(1):135-41. PubMed ID: 16377082
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of cytochrome P450 enzymes in normal and tumor tissues from childhood rhabdomyosarcoma.
Molina-Ortiz D; Camacho-Carranza R; González-Zamora JF; Shalkow-Kalincovstein J; Cárdenas-Cardós R; Ností-Palacios R; Vences-Mejía A
PLoS One; 2014; 9(4):e93261. PubMed ID: 24699256
[TBL] [Abstract][Full Text] [Related]
30. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity.
Hakkola J; Pelkonen O; Pasanen M; Raunio H
Crit Rev Toxicol; 1998 Jan; 28(1):35-72. PubMed ID: 9493761
[TBL] [Abstract][Full Text] [Related]
31. Transcript profiling of cytochrome P450 genes in HL-60 human leukemic cells: upregulation of CYP1B1 by all-trans-retinoic acid.
Kawai M; Chen J; Cheung CY; Chang TK
Mol Cell Biochem; 2003 Jun; 248(1-2):57-65. PubMed ID: 12870655
[TBL] [Abstract][Full Text] [Related]
32. Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: lower levels of CYP1B1 and increased expression of S-COMT.
Hevir N; Sinkovec J; Rižner TL
Mol Cell Endocrinol; 2011 Jan; 331(1):158-67. PubMed ID: 20887769
[TBL] [Abstract][Full Text] [Related]
33. Characterization of cytochrome P450 enzymes in human breast tissue from reduction mammaplasties.
Hellmold H; Rylander T; Magnusson M; Reihnér E; Warner M; Gustafsson JA
J Clin Endocrinol Metab; 1998 Mar; 83(3):886-95. PubMed ID: 9506744
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a real-time polymerase chain reaction method for the quantification of CYP1B1 gene expression in MCF-7 human breast carcinoma cells.
Cheung CY; Chen J; Chang TK
J Pharmacol Toxicol Methods; 2004; 49(2):97-104. PubMed ID: 14990334
[TBL] [Abstract][Full Text] [Related]
35. Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.
Delozier TC; Kissling GE; Coulter SJ; Dai D; Foley JF; Bradbury JA; Murphy E; Steenbergen C; Zeldin DC; Goldstein JA
Drug Metab Dispos; 2007 Apr; 35(4):682-8. PubMed ID: 17220242
[TBL] [Abstract][Full Text] [Related]
36. Gene-environment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosal cells.
Spivack SD; Hurteau GJ; Jain R; Kumar SV; Aldous KM; Gierthy JF; Kaminsky LS
Cancer Res; 2004 Sep; 64(18):6805-13. PubMed ID: 15375000
[TBL] [Abstract][Full Text] [Related]
37. Genistein Affects Expression of Cytochrome P450 (CYP450) Genes in Hepatocellular Carcinoma (HEPG2/C3A) Cell Line.
Lepri SR; Sartori D; Semprebon SC; Baranoski A; Coatti GC; Mantovani MS
Drug Metab Lett; 2018; 12(2):138-144. PubMed ID: 29984664
[TBL] [Abstract][Full Text] [Related]
38. Significant role of CYP450 genetic variants in cyclophosphamide based breast cancer treatment outcomes: a multi-analytical strategy.
Tulsyan S; Agarwal G; Lal P; Mittal B
Clin Chim Acta; 2014 Jul; 434():21-8. PubMed ID: 24768782
[TBL] [Abstract][Full Text] [Related]
39. [Expression of cytochrome P450 related genes in oral submucous fibrosis tissue].
Xie H; Liu J; Ling TY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Dec; 47(12):743-7. PubMed ID: 23328101
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling of cytochromes P450, ABC transporters and their principal transcription factors in the amygdala and prefrontal cortex of alcoholics, smokers and drug-free controls by qRT-PCR.
Toselli F; de Waziers I; Dutheil M; Vincent M; Wilce PA; Dodd PR; Beaune P; Loriot MA; Gillam EM
Xenobiotica; 2015; 45(12):1129-37. PubMed ID: 26095139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
